Synapse - A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)

A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC) Meeting Abstract

Authors:	Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; Boyle, J.; Patel, S. G.; Haque, S.; Katabi, N.; Ghossein, R. A.; McBride, S. M.; Michel, L. S.; Wong, R. J.; Lee, N. Y.; Pfister, D. G.
Abstract Title:	A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680305039
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.TPS6109
Notes:	Meeting Abstract: TPS6109 -- This meeting was also held virtually -- Source: Wos